Shares Outstanding (Quarterly) Chart

View Shares Outstanding (Quarterly) for LITS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Shares Outstanding (Quarterly) Chart
Start Trial

Historical Shares Outstanding (Quarterly) Data

View and export this data back to 2003. Start Trial.
Date Value
March 31, 2026 35.16M
December 31, 2025 36.65M
September 30, 2025 35.66M
June 30, 2025 6.663M
March 31, 2025 6.663M
December 31, 2024 6.663M
September 30, 2024 6.663M
June 30, 2024 6.663M
March 31, 2024 6.663M
December 31, 2023 6.663M
September 30, 2023 6.663M
June 30, 2023 6.663M
March 31, 2023 6.663M
December 31, 2022 6.663M
September 30, 2022 6.663M
June 30, 2022 6.658M
March 31, 2022 6.658M
December 31, 2021 6.645M
September 30, 2021 5.634M
June 30, 2021 5.631M
March 31, 2021 5.630M
December 31, 2020 5.626M
September 30, 2020 5.626M
June 30, 2020 5.576M
March 31, 2020 5.30M
Date Value
December 31, 2019 5.30M
September 30, 2019 3.683M
June 30, 2019 3.677M
March 31, 2019 3.564M
December 31, 2018 3.557M
September 30, 2018 3.556M
June 30, 2018 3.520M
March 31, 2018 1.866M
December 31, 2017 1.853M
September 30, 2017 1.848M
June 30, 2017 1.839M
March 31, 2017 1.839M
December 31, 2016 1.839M
September 30, 2016 1.839M
June 30, 2016 1.708M
March 31, 2016 1.708M
December 31, 2015 1.708M
September 30, 2015 1.708M
June 30, 2015 1.708M
March 31, 2015 1.708M
December 31, 2014 1.665M
September 30, 2014 1.080M
June 30, 2014 1.080M
March 31, 2014 1.080M
December 31, 2013 1.075M

Shares Outstanding Definition

The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.

Read full definition.

Shares Outstanding (Quarterly) Range, Past 5 Years

View Shares Outstanding (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Shares Outstanding (Quarterly) Benchmarks

View Shares Outstanding (Quarterly) Benchmarks
Start Trial
SELLAS Life Sciences Group, Inc. 201.92M
ACADIA Pharmaceuticals, Inc. 172.13M
Alnylam Pharmaceuticals, Inc. 133.73M
Anika Therapeutics, Inc. 13.38M
Savara, Inc. 205.40M